| Upcoming events on EXACT SCIENCES CORPORATION |
|
| 05/04/21 | | Q1 2021 Earnings Release |
| 05/04/21 | 05:00pm | | Q1 2021 Earnings Call |
| 08/04/21 | | Interim 2021 Earnings Release (Projected) |
| 11/02/21 | | Q3 2021 Earnings Release (Projected) |
|
| Past events on EXACT SCIENCES CORPORATION |
|
| 03/09/21 | 09:10am | | Barclays Global Healthcare Conference |
| 03/02/21 | 11:50am | | Cowen & Co. Health Care Conference |
| 02/25/21 | 01:40pm | | SVB Leerink Global Healthcare Conference |
| 02/24/21 | 09:50am | | Citigroup Healthcare Services, Medtech, Tools, & HCIT Virtual Conference |
|
| Upcoming sector events for EXACT SCIENCES CORPORATION |
|
|
| |
|
| Past sector events for EXACT SCIENCES CORPORATION |
|
|
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M $ |
Released
Forecast
Spread | 99,4
99,2
0,19% | 266
266
-0,01% | 454
453
0,27% | 876
878
-0,22% | 1 491
1 472
1,3% |
1 733
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -158
-162
2,7% | -104
-109
4,7% | -139
-138
-0,38% | -121
-147
18% | 26,1
-32,3
181% |
-248
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -169
-174
2,9% | -118
-124
4,7% | -159
-164
2,7% | -171
-179
4,3% | -137
-221
38% |
-470
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -167
-173
3,2% | -115
-122
5,9% | -175
-179
2,2% | -269
-212
-27% | -857
-427
-101% |
-593
|
Net income
M $ |
Released
Forecast
Spread | -167
-173
3,1% | -114
-122
6,0% | -175
-180
2,8% | -84,0
-211
60% | -849
-391
-117% |
-586
|
EPS
$ |
Released
Forecast
Spread | -1,63
-1,69
3,8% | -0,99
-1,05
5,9% | -1,43
-1,48
3,3% | -0,64
-1,61
60% | -5,61
-2,71
-107% |
-3,42
| | Announcement Date | 02/21/2017 | 02/22/2018 | 02/21/2019 | 02/11/2020 | 02/16/2021 | |
|
|
|
| Quarterly results | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) |
Sales
M $ |
Released
Forecast
Spread | 118
109
8,4% | 143
142
0,87% | 162
153
5,9% | 200
182
9,7% | 219
216
1,2% | 296
298
-0,69% | 348
347
0,10% | 269
228
18% | 408
337
21% | 466
447
4,3% |
394
|
419
|
446
|
478
|
469
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -35,4
-35,3
-0,19% | -43,2
-46,9
8,0% | -61,9
-62,9
1,6% | -26,7
-52,7
49% | -27,3
-36,6
26% | -16,4
-28,8
43% | -35,0
-28,2
-24% | -43,7
-34,9
-25% | 57,2
3,10
1 742% | 47,5
51,9
-8,5% |
-54,2
|
-53,2
|
-52,8
|
-47,6
|
-53,7
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -40,9
-47,5
14% | -49,3
-54,2
9,0% | -68,2
-74,2
8,1% | -33,8
-61,7
45% | -35,7
-46,2
23% | -42,4
-38,5
-10% | -74,3
-74,1
-0,30% | -84,8
-81,5
-3,9% | 14,0
-62,6
122% | 7,65
-0,69
1 212% |
-138
|
-106
|
-110
|
-117
|
-121
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -45,3
-55,6
18% | -54,0
-56,9
5,1% | -83,5
-80,3
-4,0% | -38,9
-70,1
45% | -39,8
-50,2
21% | -107
-46,2
-131% | -107
-107
-0,21% | -87,0
-133
35% | -224
-84,6
-165% | -438
-24,4
-1 696% |
-177
|
-134
|
-138
|
-145
|
-151
|
Net income
M $ |
Released
Forecast
Spread | -45,4
-54,7
17% | -54,0
-58,4
7,5% | -83,1
-80,4
-3,3% | -38,4
-70,8
46% | -40,5
-50,8
20% | 77,9
-46,8
267% | -106
-103
-2,3% | -86,1
-107
19% | -220
-81,5
-170% | -437
-28,7
-1 423% |
-167
|
-134
|
-140
|
-147
|
-152
|
EPS
$ |
Released
Forecast
Spread | -0,37
-0,44
15% | -0,44
-0,48
8,9% | -0,66
-0,65
-0,79% | -0,30
-0,55
46% | -0,31
-0,40
23% | 0,54
-0,33
262% | -0,71
-0,67
-6,0% | -0,58
-0,71
19% | -1,46
-0,53
-178% | -2,79
-0,20
-1 321% |
-1,00
|
-0,79
|
-0,80
|
-0,84
|
-0,86
| | Announcement Date | 10/30/2018 | 02/21/2019 | 04/30/2019 | 07/29/2019 | 10/29/2019 | 02/11/2020 | 05/06/2020 | 07/30/2020 | 10/27/2020 | 02/16/2021 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
